Skip to main content
. 2022 Feb 2;12:1810. doi: 10.1038/s41598-022-05951-z

Table 1.

Baseline data and comorbidities before the index hospitalization or death.

Myocarditis Reference population p-value
Age < 50 years 5524 (63.7) 11,009 (66.2)
Women 2181 (25.1) 4044 (24.3)
Year
2000–2004 2560 (29.5) 4783 (28.8)
2005–2009 2754 (31.7) 5297 (31.9)
2010–2014 3365 (38.8) 6542 (39.4)
Cancer (all forms) 518 (6.0) 658 (4.0)  < 0.0001
Hypertension 876 (10.1) 800 (4.8)  < 0.0001
Diabetes 485 (5.6) 410 (2.5)  < 0.0001
Myocardial infarction 659 (7.6) 318 (1.9)  < 0.0001
Any coronary heart disease 1074 (12.4) 655 (3.9)  < 0.0001
Any cardiovascular disease 2604 (30.0) 2046 (12.3)  < 0.0001
Heart failure/dilated cardiomyopathy 882 (10.2) 81 (0.5)  < 0.0001
Acute pericarditis 291 (3.4) 5 (0.0)  < 0.0001
Atrial fibrillation 798 (9.2) 363 (2.2)  < 0.0001
Ventricular tachycardia/Torsade de pointes 92 (1.1) 22 (0.1)  < 0.0001
Supra ventricular tachycardia 61 (0.7) 35 (0.2)  < 0.0001
Atrioventricular block II/III 75 (0.9) 33 (0.2)  < 0.0001
Sick sinus syndrome 52 (0.6) 30 (0.2)  < 0.0001

Description of age, gender, incidence period and of relevant comorbidities prior to diagnosis in all individuals with myocarditis in Sweden from 2000 to 2014, as well as in their age and gender matched controls.